All companies
LO

Longbio B

01779
IPO Upcoming
IPO UpcomingHong KongHKHong Kong(SEHK)Best valuation 0 markets

Official IPO

Priced· SEHK· Listing market: Hong KongHK Hong Kong
Priced
Jun 4, 2026
IPO price
Shares offered
Raise

Sources: hkex

No quoted sources for this company yet.

About Longbio B

Longbio B is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.

What the company does

  • Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
  • Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
  • Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.

Business profile

Longbio B belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.